Prognosis

Australia Backs AstraZeneca Vaccine as Blood Clots Probed

Vials of the AstraZeneca Plc and the University of Oxford Covid-19 vaccine.

Photographer: Anthony Devlin/Bloomberg
Lock
This article is for subscribers only.

For a fresh perspective on the stories that matter for Australian business and politics, sign up for our weekly newsletter.

Australia won’t pause the rollout of AstraZeneca Plc’s Covid-19 vaccine, even as some European countries temporarily suspend use of the shots while possible blood clots are investigated.